Lupus Suppressant Hydroxychloroquine To Expand At A CAGR Of 4.5% During The Forecast Period 2022-2032

Chemical & Materials

In the wake of the worsening coronavirus pandemic, Lupus Suppressant hydroxychloroquine has been touted as a key drug in the treatment and eradication of COVID-19. As a result, the demand for Lupus Suppressant hydroxychloroquine has skyrocketed in the past few weeks. The United States alone has generated significant demand for 20 million hydroxychloroquine pills, amounting to 4 tons. Moreover, the global demand for hydroxychloroquine is anticipated to surge amid the rapidly increasing COVID-19 infections. In 2020, from January to April, India has exported hydroxychloroquine API (active pharmaceutical ingredient) worth US$ 1.2 Bn. Attributed to above-mentioned facts global Lupus Suppressant hydroxychloroquine market is estimated to experience a year on year growth of over 100% by the end of 2020.

For More Insights Into The Market, Request a Sample of this Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=4769

Key Takeaways of Hydroxychloroquine Market Study

  • Due to skyrocketing demand for hydroxychloroquine, the global hydroxychloroquine market is expected to create a value opportunity of around US$ 2.3 Bn by the end of 2020.
  • The coronavirus pandemic has spiked the prices of API (active pharmaceutical ingredients) which is set to increase the market value by 2X through 2020.
  • Based on drug type, anti-rheumatic drug has dominated the consumption of hydroxychloroquine in 2018 and is poised to account for nearly half of the market share by 2030.
  • Due to the high prevalence of rheumatoid arthritis and systemic lupus erythematosus, United Stated is projected to remain a highly lucrative region during the forecast period.
  • In terms of production, currently, India accounted for nearly half of the global production in 2019.

Key Segments Covered in the Hydroxychloroquine Industry Survey

  • Hydroxychloroquine by Drug Type
    • Anti-malarial Hydroxychloroquine Drug
    • Anti-rheumatic Hydroxychloroquine Drug
    • Lupus Suppressant Hydroxychloroquine Drug
    • Anti-COVID 19 Hydroxychloroquine Drug
    • Other Hydroxychloroquine Drugs
  • Hydroxychloroquine by Region
    • North America Hydroxychloroquine Market
    • Latin America Hydroxychloroquine Market
    • Europe Hydroxychloroquine Market
    • Asia Pacific Hydroxychloroquine Market
    • Middle East & Africa Hydroxychloroquine Market

Key Companies Profiled

  • Abcam Plc.
  • Advanz Pharma Group
  • Amneal Pharmaceuticals Inc.
  • Bayer AG
  • Dr. Reddy’s Laboratories
  • Ipca Laboratories
  • Laurus Labs
  • Mylan N.V (Viatris)
  • Novartis AG (Sandoz)
  • Prasco Laboratories
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Wallace Pharmaceuticals Ltd.
  • Zydus Cadila

 

Leave a Reply

Related Posts